Creative Details

Quality Score: 4/10

The advertisement promotes Reblozyl, a prescription medication for treating anemia in adults with myelodysplastic syndromes (MDS). It emphasizes the importance of discussing medical conditions with a healthcare provider before use.

Creative Information

CID:7063d2b5-843c-4d43-93de-44591d533363
CRID:82_7372-888379
Domain:reblozyl.com
Seat:PP
Size:300x250
Bid:$7.60
Timestamp:10/31/2025, 7:09:29 PM
Declared IAB Categories:

    Analysis

    5 succeeded(100% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysissuccess10/31/2025, 9:03:24 PM6.36s
    adomain_analysissuccess10/31/2025, 9:32:49 PM3.78s
    adomain_capturesuccess10/31/2025, 9:32:45 PM0.16s
    ad_rendersuccess10/31/2025, 9:03:18 PM25.12s
    brand_mappingsuccess10/31/2025, 9:32:47 PM1.98s

    Analysis Results

    Ad Format: banner

    Brands: Reblozyl

    Sensitive:Pharmaceutical Products
    Quality:Adomain not match landing page domain
    Size:300x250
    Data Transferred:1634.83 KB
    Render Time:9.40 Seconds
    Creative Inferred IAB Categories:
    • Health & Fitness (IAB7)
    • Society (IAB14)
    Creative Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Domain Inferred IAB Categories:
    • Health & Fitness (IAB7)
    Domain Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Landing Page:
    Total Ad Size:1655.05 KB
    Requests Made:
    URLSize (KB)
    https://cdn.doubleverify.com/dvbm.js523.93
    https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js221.47
    https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_287.js116.69
    https://ad.doubleclick.net/ddm/adj/N2173150.3848558MATTERKIND/B32783474.420204801;dc_ver=106.314;sz=300x250;u_sd=1;gpp_sid=AUDIT;gpp=AUDIT;gdpr_consent=AUDIT;nel=1;kw=2524195;dc_adk=3706686476;ord=qpaiuy;click=https%3A%2F%2Fsjc-tr.contextweb.com%2Fbh%2Fct2%3Fi%3DLxQ0PNK5KH2C~a%3D6b3c03c88d40d8562571003bd56b890a26435aa9~agi%3D240155~ts%3Ds6YkQ5bIZS8k_UusPWpxtpxbUUTGFTmf~es%3D2~gdprc%3DCQXA6UAQXA6UAAOADBENB5FoAP_gAEPgACiQKZNB9G7WTWFjeTp2YPskOYwH0VBJ4MAwBgCBAUABzBIUIBwGRmAxJAyIICACGAIAIGBBIABlGABAQEAAIIAFAABIAEgAIBAAICAAAAAAAABACAAAAAAAAAAQgEAVMBQgmAYEBFoIQUhAggAAAQAAAAAEAIABAAQAAAAAQAAACAAAACgAAgAAAAAAAAAEAFAIAAAAIAECAgskdAAAAAAAAAAIAAYAAAABBVMAEg0KiCIsCAEIhAwggQACCgIAKBAEAAAQIAAACYIChAGACowGQAgBAAAAAAAAAAAAIAAAIAEIAAgAABAAAAABAAEABAAAAAQAAAAAAAAAAAAAAAAAAAAAAAAAxAIEEAQAAIIACCgAAAAEAAAAAAAAABEAAQAAAAAAAAAAAAAAEAAAAAAAAAAAAAAAAAABAgAABAAAAFAYgsAAAAAAAAAAAAAAAQAAIAAAABAA.YAAAAAAABZTwAA~c%3D2524195~p%3D562001~pu%3Dhttps%253A%252F%252Fwww.slashgear.com%252F2002334%252Fus-navy-ships-being-decommissioned-in-2026%252F~s%3Dcontextweb.com~dt%3D4~u%3D;uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.;dc_rfl=1,https%3A%2F%2Fecho-server.dangoldin.workers.dev%2F$0;xdt=0;crlt=M8Mu6SOYpu;gcsr=m;stc=1;chaa=1;sttr=107;prcl=s101.40
    https://ajax.googleapis.com/ajax/libs/jquery/1.11.0/jquery.min.js94.12
    https://cdn.jsdelivr.net/npm/[email protected]/dist/gsap.min.js70.52
    https://www.googletagservices.com/dcm/impl_v106.js68.78
    https://ep1.adtrafficquality.google/bg/d_CiwsBz4C1JnuQWQa80FmGcfeOOSGcvq61yBJQq_4U.js52.61
    https://fonts.gstatic.com/l/font?kit=memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVfS2svGaA3dSho-oytysBbmcP95okSwdwoCR_XMuvRvVuE57r6z3xIL2pht6WoxiOtaF7nsP9EFOf7U6wfCxaEx3FcQ5YcwgOih3JkqOv&skey=62c1cbfccc78b4b2&v=v4444.13
    https://ep2.adtrafficquality.google/sodar/VFc2VJAc.js42.74

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Landing Page

    Landing Page

    Creatives

    Creative Screenshot 1Creative Screenshot 2Creative Screenshot 3